HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lactosylceramide in inflammatory bowel disease: a biochemical study.

Abstract
A simple technique for isolating lipids from small pieces of tissue was applied to mucosal biopsies and samples of resected intestine from patients with inflammatory bowel disease. Scanning densitometry of two dimensional chromatograms showed increased concentrations of the membrane associated glycosphingolipid lactosylceramide in Crohn's disease, on comparison with ulcerative colitis (p less than 0.01), or controls (p less than 0.01). This indicates either that normal glycosphingolipid metabolism is altered, or that a novel source of lactosylceramide is present in the inflamed mucosa of patients with Crohn's disease.
AuthorsC R Stevens, V G Oberholzer, J A Walker-Smith, A D Phillips
JournalGut (Gut) Vol. 29 Issue 5 Pg. 580-7 (May 1988) ISSN: 0017-5749 [Print] England
PMID3396945 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD
  • Glycosphingolipids
  • Lactosylceramides
  • Phosphatidylethanolamines
  • CDw17 antigen
Topics
  • Adolescent
  • Adult
  • Antigens, CD
  • Child
  • Chromatography, Thin Layer
  • Colitis, Ulcerative (metabolism)
  • Crohn Disease (metabolism)
  • Densitometry
  • Female
  • Glycosphingolipids (analysis)
  • Humans
  • Intestinal Mucosa (analysis)
  • Lactosylceramides
  • Male
  • Phosphatidylethanolamines (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: